Palo Alto Investors LP - 30 Sep 2024 SCHEDULE 13G/A Report for Revance Therapeutics, Inc. Common Stock (RVNC)

Filing Manager
Palo Alto Investors LP
Reporting Manager
Patrick Lee, MD
Security
Revance Therapeutics, Inc. Common Stock
Symbol
RVNC
Shares outstanding
104,661,494 shares
Disclosed Ownership
1,611,787 shares
Ownership
1.54%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2025, 16:02:42 UTC
Date of event
30 Sep 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Patrick Lee, MD 1.54% 1,611,787 0 1,611,787 Patrick Lee, MD Patrick Lee, MD
Anthony Joonkyoo Yun, MD 1.54% 1,611,787 0 1,611,787 Anthony Joonkyoo Yun, MD Anthony Joonkyoo Yun
Palo Alto Investors LP 1.54% 1,611,787 0 1,611,787 Angela Nguyen-Dinh Angela Nguyen-Dinh, Chief Compliance Officer
PAI LLC 1.54% 1,611,787 0 1,611,787 Patrick Lee, MD Patrick Lee, MD, Managing Member